Cell-Based Therapy of Myocardial Infarction

Arteriosclerosis, Thrombosis, and Vascular Biology - Tập 28 Số 2 - Trang 208-216 - 2008
Stefanie Dimmeler1,2, Jana Burchfield1, Andreas M. Zeiher1
1From Molecular Cardiology, Department of Internal Medicine III, University of Frankfurt, Germany.
2Molecular Cardiology, Department of Internal Medicine III, University of Frankfurt, Theodor Stern-Kai 7, 60590 Frankfurt, Germany.

Tóm tắt

Cell-based therapy is a promising option for treatment of ischemic diseases. Several cell types have experimentally been shown to increase the functional recovery of the heart after ischemia by physically forming new blood vessels, differentiating to cardiac myocytes and—additionally or alternatively—by providing proangiogenic and antiapoptotic factors promoting tissue repair in a paracrine manner. Clinical studies preferentially used adult bone marrow–derived cells for the treatment of patients with acute myocardial infarction. Most of the studies suggested that cell therapy reduced the infarct size and improved cardiac contractile function. However, cell therapy is in its early stages, and various questions remain. For example, the identification of those patients who benefit most from cell therapy, the optimal cell type and number for patient with acute and chronic diseases, the best time and way of cell delivery, and the mechanisms of action by which cells exhibit beneficial effects, need to be further evaluated. Although no major safety concerns were raised during the initial clinical trials, several potential side effects need to be carefully monitored. The present review article summarizes the results of the clinical studies and discusses the open issues.

Từ khóa


Tài liệu tham khảo

10.1634/stemcells.2006-0623

10.1172/JCI200524283

10.1038/nm1618

10.1172/JCI12150

10.1161/circ.105.1.93

10.1038/nature00870

10.1161/01.res.0000137877.89448.78

10.1038/nm0603-702

10.1016/j.exphem.2007.04.002

10.1161/01.cir.0000058702.69484.a0

10.1016/j.cell.2005.10.036

10.1073/pnas.0604203103

10.1038/nm963

10.1083/jcb.200506123

10.1083/jcb.200512085

10.1161/01.atv.0000156402.52029.ce

10.1038/ncpcardio0444

10.1091/mbc.e02-02-0105

10.1016/S0092-8674(03)00687-1

10.1073/pnas.2132126100

10.1016/S0014-5793(02)03477-4

10.1038/nature03215

10.1161/01.res.0000147315.71699.51

10.1161/circulationaha.106.655209

10.1083/jcb.200504061

10.1172/JCI27019

10.1161/01.res.0000194330.66545.f5

10.1002/jcb.20949

10.1038/ncpcardio0441

10.1161/01.cir.0000043246.74879.cd

10.1161/01.res.0000214407.58341.c8

10.1161/circulationaha.106.687376

10.1161/01.cir.0000034046.87607.1c

10.1016/S0140-6736(04)16626-9

10.1161/01.res.0000144798.54040.ed

10.1016/S0140-6736(05)67861-0

10.1080/14017430510009131

Seeger FH Tonn T Krzossok N Zeiher AM Dimmeler S. Cell isolation procedures matter: a comparison of different isolation protocols of bone marrow mononuclear cells used for cell therapy in patients with acute myocardial infarction. Eur Heart J. 2007.

10.1056/NEJMoa060186

10.1093/eurheartj/ehl388

10.1016/j.jacc.2004.08.014

10.1161/01.cir.0000106161.43954.df

10.1016/j.jacc.2006.01.039

10.1093/eurheartj/ehl235

10.1161/01.cir.0000134696.08436.65

10.1182/blood-2006-12-063412

10.1161/01.cir.0000046450.89986.50

10.1016/j.yjmcc.2005.07.003

10.1161/CIRCULATIONAHA.106.671545

10.1038/nm0405-367

10.1161/01.res.0000225952.61196.39

10.1038/ncpcardio0770

10.1080/14653240601045399

10.1038/86498

10.1016/j.febslet.2007.07.028

10.1038/35070587

10.1038/nature02446

10.1161/circ.88.2.8339405

10.1016/j.jacc.2005.01.041

10.1056/NEJMoa051779

Thông tin
Thông tin xuất bản

Arteriosclerosis, Thrombosis, and Vascular Biology

Tập 28 Số 2

208-216

Thông tin tác giả